| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | intermediate filament organization | 4.11e-06 | 75 | 30 | 4 | GO:0045109 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 7.25e-06 | 189 | 30 | 5 | GO:0030216 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.24e-05 | 99 | 30 | 4 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.29e-05 | 100 | 30 | 4 | GO:0045103 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 2.48e-05 | 870 | 30 | 8 | GO:0030855 | |
| GeneOntologyBiologicalProcess | positive regulation of protein ubiquitination | 3.02e-05 | 124 | 30 | 4 | GO:0031398 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 5.13e-05 | 284 | 30 | 5 | GO:0009913 | |
| GeneOntologyBiologicalProcess | protein polyubiquitination | 5.58e-05 | 289 | 30 | 5 | GO:0000209 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification by small protein conjugation or removal | 6.36e-05 | 150 | 30 | 4 | GO:1903322 | |
| GeneOntologyBiologicalProcess | positive regulation of post-translational protein modification | 6.52e-05 | 151 | 30 | 4 | GO:1901875 | |
| GeneOntologyBiologicalProcess | protein ubiquitination | 1.30e-04 | 811 | 30 | 7 | GO:0016567 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.84e-04 | 14 | 30 | 2 | GO:0060213 | |
| GeneOntologyBiologicalProcess | skin development | 1.85e-04 | 373 | 30 | 5 | GO:0043588 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | 2.36e-04 | 893 | 30 | 7 | GO:0032446 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.42e-04 | 16 | 30 | 2 | GO:0060211 | |
| GeneOntologyBiologicalProcess | regulation of protein ubiquitination | 3.08e-04 | 226 | 30 | 4 | GO:0031396 | |
| GeneOntologyBiologicalProcess | epidermis development | 4.90e-04 | 461 | 30 | 5 | GO:0008544 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | 4.96e-04 | 1009 | 30 | 7 | GO:0070647 | |
| GeneOntologyBiologicalProcess | regulation of protein modification by small protein conjugation or removal | 6.10e-04 | 271 | 30 | 4 | GO:1903320 | |
| GeneOntologyBiologicalProcess | regulation of post-translational protein modification | 6.62e-04 | 277 | 30 | 4 | GO:1901873 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | 7.21e-04 | 1074 | 30 | 7 | GO:0043687 | |
| GeneOntologyBiologicalProcess | epithelium development | 9.22e-04 | 1469 | 30 | 8 | GO:0060429 | |
| GeneOntologyBiologicalProcess | proteolysis involved in protein catabolic process | 9.65e-04 | 812 | 30 | 6 | GO:0051603 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 1.05e-03 | 33 | 30 | 2 | GO:0000289 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 2.82e-04 | 899 | 31 | 7 | GO:0099513 | |
| GeneOntologyCellularComponent | intermediate filament | 3.38e-04 | 227 | 31 | 4 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 5.90e-04 | 263 | 31 | 4 | GO:0045111 | |
| Domain | UBA-like | 3.21e-06 | 64 | 30 | 4 | IPR009060 | |
| Domain | Ago_hook | 7.48e-06 | 3 | 30 | 2 | PF10427 | |
| Domain | TNRC6-PABC_bdg | 7.48e-06 | 3 | 30 | 2 | PF16608 | |
| Domain | TNRC6_PABC-bd | 7.48e-06 | 3 | 30 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 7.48e-06 | 3 | 30 | 2 | IPR019486 | |
| Domain | - | 3.73e-05 | 6 | 30 | 2 | 3.90.1290.10 | |
| Domain | Plectin_repeat | 5.21e-05 | 7 | 30 | 2 | IPR001101 | |
| Domain | Plectin | 5.21e-05 | 7 | 30 | 2 | PF00681 | |
| Domain | PLEC | 5.21e-05 | 7 | 30 | 2 | SM00250 | |
| Domain | GrpE_coiled_coil | 1.63e-04 | 12 | 30 | 2 | IPR013805 | |
| Domain | Keratin_II | 7.91e-04 | 26 | 30 | 2 | IPR003054 | |
| Domain | Spectrin_repeat | 9.86e-04 | 29 | 30 | 2 | IPR002017 | |
| Domain | UBA | 1.06e-03 | 30 | 30 | 2 | SM00165 | |
| Domain | Spectrin/alpha-actinin | 1.20e-03 | 32 | 30 | 2 | IPR018159 | |
| Domain | SPEC | 1.20e-03 | 32 | 30 | 2 | SM00150 | |
| Domain | UBA | 1.52e-03 | 36 | 30 | 2 | PF00627 | |
| Domain | ARM-type_fold | 2.01e-03 | 339 | 30 | 4 | IPR016024 | |
| Domain | UBA | 2.26e-03 | 44 | 30 | 2 | IPR015940 | |
| Domain | Keratin_I | 2.26e-03 | 44 | 30 | 2 | IPR002957 | |
| Domain | UBA | 2.58e-03 | 47 | 30 | 2 | PS50030 | |
| Domain | Intermediate_filament_CS | 4.58e-03 | 63 | 30 | 2 | IPR018039 | |
| Domain | Prefoldin | 5.95e-03 | 72 | 30 | 2 | IPR009053 | |
| Domain | IF | 5.95e-03 | 72 | 30 | 2 | PS00226 | |
| Domain | Filament | 6.11e-03 | 73 | 30 | 2 | PF00038 | |
| Domain | IF | 6.60e-03 | 76 | 30 | 2 | IPR001664 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 3.38e-05 | 41 | 22 | 3 | M29748 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 3.47e-05 | 6 | 22 | 2 | MM15083 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 4.86e-05 | 7 | 22 | 2 | M46421 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 5.80e-05 | 49 | 22 | 3 | MM14837 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 8.31e-05 | 9 | 22 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 8.31e-05 | 9 | 22 | 2 | M46436 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 1.04e-04 | 10 | 22 | 2 | M48013 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 1.79e-04 | 13 | 22 | 2 | M46434 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 2.22e-04 | 197 | 22 | 4 | M27188 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 3.12e-04 | 17 | 22 | 2 | M27788 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 3.21e-04 | 87 | 22 | 3 | MM15351 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 3.91e-04 | 19 | 22 | 2 | M48238 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 7.65e-04 | 117 | 22 | 3 | M19248 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 8.57e-04 | 28 | 22 | 2 | M48253 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.02e-03 | 129 | 22 | 3 | M27649 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 1.12e-03 | 32 | 22 | 2 | M48012 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.12e-03 | 32 | 22 | 2 | M27900 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.26e-03 | 139 | 22 | 3 | M715 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 1.27e-03 | 34 | 22 | 2 | M46422 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 1.34e-03 | 35 | 22 | 2 | M27190 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.50e-03 | 37 | 22 | 2 | M29790 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 1.50e-03 | 37 | 22 | 2 | MM14488 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 1.58e-03 | 38 | 22 | 2 | M495 | |
| Pathway | REACTOME_KERATINIZATION | 1.66e-03 | 153 | 22 | 3 | MM15343 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.72e-03 | 155 | 22 | 3 | M522 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.84e-03 | 41 | 22 | 2 | MM15200 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 2.41e-03 | 47 | 22 | 2 | M29777 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 2.62e-03 | 49 | 22 | 2 | M48250 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 2.62e-03 | 49 | 22 | 2 | MM15448 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 2.94e-03 | 52 | 22 | 2 | M2341 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 9.84e-11 | 430 | 31 | 9 | 35044719 | |
| Pubmed | 2.52e-09 | 418 | 31 | 8 | 34709266 | ||
| Pubmed | 1.89e-07 | 288 | 31 | 6 | 23383273 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 6.65e-07 | 583 | 31 | 7 | 29844126 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 7.04e-07 | 588 | 31 | 7 | 38580884 | |
| Pubmed | 7.29e-07 | 591 | 31 | 7 | 15231748 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 29791863 | ||
| Pubmed | Epithelial structural proteins of the skin and oral cavity: function in health and disease. | 7.69e-07 | 2 | 31 | 2 | 11132762 | |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 9.48e-07 | 84 | 31 | 4 | 29563501 | |
| Pubmed | 1.09e-06 | 87 | 31 | 4 | 12465718 | ||
| Pubmed | 1.46e-06 | 25 | 31 | 3 | 32528060 | ||
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 2.31e-06 | 3 | 31 | 2 | 34108231 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 16880270 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 31670606 | ||
| Pubmed | 2.89e-06 | 1429 | 31 | 9 | 35140242 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.34e-06 | 774 | 31 | 7 | 15302935 | |
| Pubmed | TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation. | 4.61e-06 | 4 | 31 | 2 | 37324936 | |
| Pubmed | Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. | 4.61e-06 | 4 | 31 | 2 | 21063388 | |
| Pubmed | Large-scale analysis of the human ubiquitin-related proteome. | 8.02e-06 | 313 | 31 | 5 | 16196087 | |
| Pubmed | 1.25e-05 | 1285 | 31 | 8 | 35914814 | ||
| Pubmed | 1.61e-05 | 7 | 31 | 2 | 19383768 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 1.61e-05 | 7 | 31 | 2 | 19470757 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 2.04e-05 | 182 | 31 | 4 | 31067453 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.13e-05 | 184 | 31 | 4 | 32908313 | |
| Pubmed | 2.15e-05 | 655 | 31 | 6 | 35819319 | ||
| Pubmed | 2.76e-05 | 9 | 31 | 2 | 15500642 | ||
| Pubmed | 2.76e-05 | 9 | 31 | 2 | 12482924 | ||
| Pubmed | Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. | 2.82e-05 | 66 | 31 | 3 | 24811749 | |
| Pubmed | 4.03e-05 | 733 | 31 | 6 | 34672954 | ||
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 12802069 | ||
| Pubmed | 4.84e-05 | 79 | 31 | 3 | 27325702 | ||
| Pubmed | PAQR9 Modulates BAG6-mediated protein quality control of mislocalized membrane proteins. | 5.05e-05 | 12 | 31 | 2 | 31904842 | |
| Pubmed | 5.24e-05 | 1139 | 31 | 7 | 36417873 | ||
| Pubmed | 6.57e-05 | 486 | 31 | 5 | 20936779 | ||
| Pubmed | Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. | 6.95e-05 | 14 | 31 | 2 | 19716330 | |
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 6.95e-05 | 14 | 31 | 2 | 27626314 | |
| Pubmed | MEK kinase 1 regulates c-Jun phosphorylation in the control of corneal morphogenesis. | 6.95e-05 | 14 | 31 | 2 | 14627958 | |
| Pubmed | 7.10e-05 | 494 | 31 | 5 | 26831064 | ||
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 8.02e-05 | 15 | 31 | 2 | 21981923 | |
| Pubmed | 8.56e-05 | 263 | 31 | 4 | 34702444 | ||
| Pubmed | 8.95e-05 | 266 | 31 | 4 | 19380743 | ||
| Pubmed | 9.21e-05 | 98 | 31 | 3 | 26561776 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 9.32e-05 | 853 | 31 | 6 | 28718761 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 9.56e-05 | 857 | 31 | 6 | 25609649 | |
| Pubmed | 1.00e-04 | 274 | 31 | 4 | 34244482 | ||
| Pubmed | Assembly and Function of Heterotypic Ubiquitin Chains in Cell-Cycle and Protein Quality Control. | 1.04e-04 | 17 | 31 | 2 | 29033132 | |
| Pubmed | 1.15e-04 | 284 | 31 | 4 | 29459677 | ||
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 1.16e-04 | 106 | 31 | 3 | 31024071 | |
| Pubmed | 1.16e-04 | 549 | 31 | 5 | 38280479 | ||
| Pubmed | Autoregulation of the 26S proteasome by in situ ubiquitination. | 1.30e-04 | 19 | 31 | 2 | 24743594 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 1.32e-04 | 564 | 31 | 5 | 21565611 | |
| Pubmed | EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway. | 1.60e-04 | 21 | 31 | 2 | 33029523 | |
| Pubmed | 1.76e-04 | 22 | 31 | 2 | 22187428 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.80e-04 | 123 | 31 | 3 | 26912792 | |
| Pubmed | 1.87e-04 | 608 | 31 | 5 | 16713569 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 1.89e-04 | 125 | 31 | 3 | 32891193 | |
| Pubmed | 1.92e-04 | 23 | 31 | 2 | 28811219 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 2.02e-04 | 1415 | 31 | 7 | 28515276 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 2.09e-04 | 332 | 31 | 4 | 30595499 | |
| Pubmed | 2.17e-04 | 335 | 31 | 4 | 15741177 | ||
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 2.28e-04 | 25 | 31 | 2 | 30309841 | |
| Pubmed | 2.30e-04 | 1007 | 31 | 6 | 34597346 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 2.36e-04 | 639 | 31 | 5 | 23443559 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 2.40e-04 | 344 | 31 | 4 | 30333137 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 2.50e-04 | 647 | 31 | 5 | 26618866 | |
| Pubmed | Proteomic analysis of the NOS2 interactome in human airway epithelial cells. | 2.53e-04 | 138 | 31 | 3 | 23438482 | |
| Pubmed | 2.68e-04 | 657 | 31 | 5 | 36180527 | ||
| Pubmed | 2.86e-04 | 1049 | 31 | 6 | 27880917 | ||
| Pubmed | 2.86e-04 | 28 | 31 | 2 | 29365100 | ||
| Pubmed | 2.86e-04 | 28 | 31 | 2 | 35474067 | ||
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 2.99e-04 | 146 | 31 | 3 | 20686565 | |
| Pubmed | The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein. | 3.08e-04 | 29 | 31 | 2 | 12438443 | |
| Pubmed | 3.36e-04 | 152 | 31 | 3 | 38360978 | ||
| Pubmed | 3.75e-04 | 32 | 31 | 2 | 19815544 | ||
| Pubmed | 3.75e-04 | 32 | 31 | 2 | 36278411 | ||
| Pubmed | 3.98e-04 | 1116 | 31 | 6 | 31753913 | ||
| Pubmed | TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains. | 3.99e-04 | 33 | 31 | 2 | 33567268 | |
| Pubmed | 4.08e-04 | 396 | 31 | 4 | 26687479 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 4.18e-04 | 724 | 31 | 5 | 36232890 | |
| Pubmed | 4.20e-04 | 399 | 31 | 4 | 37536630 | ||
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 4.35e-04 | 166 | 31 | 3 | 35687106 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 4.51e-04 | 736 | 31 | 5 | 29676528 | |
| Pubmed | 4.58e-04 | 169 | 31 | 3 | 31462741 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 4.66e-04 | 170 | 31 | 3 | 23314748 | |
| Pubmed | 4.75e-04 | 36 | 31 | 2 | 35379950 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 5.51e-04 | 180 | 31 | 3 | 35198878 | |
| Pubmed | The von Hippel-Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases. | 5.87e-04 | 40 | 31 | 2 | 34004371 | |
| Pubmed | 6.38e-04 | 446 | 31 | 4 | 24255178 | ||
| Pubmed | 6.47e-04 | 42 | 31 | 2 | 27578003 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 6.84e-04 | 807 | 31 | 5 | 30575818 | |
| Pubmed | 6.99e-04 | 457 | 31 | 4 | 22190034 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 7.46e-04 | 1257 | 31 | 6 | 37317656 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 7.70e-04 | 202 | 31 | 3 | 33005030 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 8.73e-04 | 211 | 31 | 3 | 24097068 | |
| Interaction | PHF21A interactions | 2.74e-08 | 343 | 30 | 8 | int:PHF21A | |
| Interaction | SMAD9 interactions | 8.86e-08 | 153 | 30 | 6 | int:SMAD9 | |
| Interaction | TFDP3 interactions | 2.27e-07 | 36 | 30 | 4 | int:TFDP3 | |
| Interaction | CYLD interactions | 2.86e-07 | 868 | 30 | 10 | int:CYLD | |
| Interaction | KRT19 interactions | 3.19e-06 | 282 | 30 | 6 | int:KRT19 | |
| Interaction | TRIM65 interactions | 5.83e-06 | 80 | 30 | 4 | int:TRIM65 | |
| Interaction | UBE2D2 interactions | 6.35e-06 | 318 | 30 | 6 | int:UBE2D2 | |
| Interaction | DDX6 interactions | 7.16e-06 | 503 | 30 | 7 | int:DDX6 | |
| Interaction | BRCA1 interactions | DNAJA3 TNRC6B ANAPC16 ITPRID2 HUWE1 PLEC DSP MAP3K1 UBR4 TNRC6A | 7.72e-06 | 1249 | 30 | 10 | int:BRCA1 |
| Interaction | KRT28 interactions | 1.18e-05 | 30 | 30 | 3 | int:KRT28 | |
| Interaction | CNOT3 interactions | 1.26e-05 | 207 | 30 | 5 | int:CNOT3 | |
| Interaction | SPATA1 interactions | 1.30e-05 | 31 | 30 | 3 | int:SPATA1 | |
| Interaction | KRT18 interactions | 3.03e-05 | 419 | 30 | 6 | int:KRT18 | |
| Interaction | TRIM37 interactions | 3.07e-05 | 630 | 30 | 7 | int:TRIM37 | |
| Interaction | KRT8 interactions | 4.03e-05 | 441 | 30 | 6 | int:KRT8 | |
| Interaction | SYNE3 interactions | 4.19e-05 | 444 | 30 | 6 | int:SYNE3 | |
| Interaction | CIC interactions | 4.67e-05 | 673 | 30 | 7 | int:CIC | |
| Interaction | TNRC6C interactions | 5.02e-05 | 138 | 30 | 4 | int:TNRC6C | |
| Interaction | KDM1A interactions | 5.12e-05 | 941 | 30 | 8 | int:KDM1A | |
| Interaction | RCOR1 interactions | 7.58e-05 | 494 | 30 | 6 | int:RCOR1 | |
| Interaction | CNOT6 interactions | 7.82e-05 | 56 | 30 | 3 | int:CNOT6 | |
| Interaction | RTL8A interactions | 1.17e-04 | 11 | 30 | 2 | int:RTL8A | |
| Interaction | PAQR9 interactions | 1.17e-04 | 11 | 30 | 2 | int:PAQR9 | |
| Interaction | ZUP1 interactions | 1.23e-04 | 174 | 30 | 4 | int:ZUP1 | |
| Interaction | YAP1 interactions | 1.48e-04 | 1095 | 30 | 8 | int:YAP1 | |
| Interaction | PRKD1 interactions | 1.53e-04 | 184 | 30 | 4 | int:PRKD1 | |
| Interaction | FAM184A interactions | 1.66e-04 | 72 | 30 | 3 | int:FAM184A | |
| Interaction | KRT36 interactions | 1.80e-04 | 74 | 30 | 3 | int:KRT36 | |
| Interaction | CNOT8 interactions | 1.80e-04 | 74 | 30 | 3 | int:CNOT8 | |
| Interaction | KRT14 interactions | 1.80e-04 | 192 | 30 | 4 | int:KRT14 | |
| Interaction | RNF208 interactions | 1.87e-04 | 75 | 30 | 3 | int:RNF208 | |
| Interaction | CRK interactions | 1.98e-04 | 370 | 30 | 5 | int:CRK | |
| Interaction | PHIP interactions | 1.99e-04 | 197 | 30 | 4 | int:PHIP | |
| Interaction | KRT16 interactions | 1.99e-04 | 197 | 30 | 4 | int:KRT16 | |
| Interaction | FEV interactions | 2.23e-04 | 203 | 30 | 4 | int:FEV | |
| Interaction | PRPH interactions | 2.27e-04 | 204 | 30 | 4 | int:PRPH | |
| Interaction | RBMS1 interactions | 2.40e-04 | 207 | 30 | 4 | int:RBMS1 | |
| Interaction | PRRC2A interactions | 2.50e-04 | 389 | 30 | 5 | int:PRRC2A | |
| Interaction | UBXN1 interactions | 2.68e-04 | 213 | 30 | 4 | int:UBXN1 | |
| Interaction | SCG2 interactions | 2.87e-04 | 17 | 30 | 2 | int:SCG2 | |
| Interaction | UNK interactions | 3.12e-04 | 408 | 30 | 5 | int:UNK | |
| Interaction | SERPINI2 interactions | 3.23e-04 | 18 | 30 | 2 | int:SERPINI2 | |
| Interaction | RAD23A interactions | 3.25e-04 | 224 | 30 | 4 | int:RAD23A | |
| Interaction | CNOT6L interactions | 3.53e-04 | 93 | 30 | 3 | int:CNOT6L | |
| Interaction | KRT33B interactions | 3.53e-04 | 93 | 30 | 3 | int:KRT33B | |
| Interaction | AGR2 interactions | 3.58e-04 | 934 | 30 | 7 | int:AGR2 | |
| Interaction | CNOT9 interactions | 3.65e-04 | 231 | 30 | 4 | int:CNOT9 | |
| Interaction | SOX17 interactions | 3.76e-04 | 95 | 30 | 3 | int:SOX17 | |
| Interaction | SRGN interactions | 4.00e-04 | 20 | 30 | 2 | int:SRGN | |
| Interaction | ATXN3 interactions | 4.36e-04 | 439 | 30 | 5 | int:ATXN3 | |
| Interaction | LATS1 interactions | 4.40e-04 | 440 | 30 | 5 | int:LATS1 | |
| Interaction | EYA4 interactions | 4.42e-04 | 243 | 30 | 4 | int:EYA4 | |
| Interaction | DNAJB2 interactions | 4.63e-04 | 102 | 30 | 3 | int:DNAJB2 | |
| Interaction | RNF113A interactions | 4.71e-04 | 692 | 30 | 6 | int:RNF113A | |
| Interaction | ELP2 interactions | 5.04e-04 | 105 | 30 | 3 | int:ELP2 | |
| Interaction | USP7 interactions | 5.11e-04 | 1313 | 30 | 8 | int:USP7 | |
| Interaction | NINL interactions | 5.29e-04 | 458 | 30 | 5 | int:NINL | |
| Interaction | DRC3 interactions | 5.32e-04 | 23 | 30 | 2 | int:DRC3 | |
| Interaction | ANKHD1-EIF4EBP3 interactions | 5.47e-04 | 108 | 30 | 3 | int:ANKHD1-EIF4EBP3 | |
| Interaction | CNOT11 interactions | 6.08e-04 | 112 | 30 | 3 | int:CNOT11 | |
| Interaction | PIH1D1 interactions | 6.29e-04 | 731 | 30 | 6 | int:PIH1D1 | |
| Interaction | GABRD interactions | 6.29e-04 | 25 | 30 | 2 | int:GABRD | |
| Interaction | NUP155 interactions | 6.36e-04 | 477 | 30 | 5 | int:NUP155 | |
| Interaction | DUSP4 interactions | 7.08e-04 | 118 | 30 | 3 | int:DUSP4 | |
| Interaction | KIZ interactions | 7.35e-04 | 27 | 30 | 2 | int:KIZ | |
| Interaction | GABRA3 interactions | 7.90e-04 | 28 | 30 | 2 | int:GABRA3 | |
| Interaction | TTC3 interactions | 8.18e-04 | 124 | 30 | 3 | int:TTC3 | |
| Interaction | SOX2 interactions | 8.67e-04 | 1422 | 30 | 8 | int:SOX2 | |
| Interaction | MAPRE1 interactions | 8.90e-04 | 514 | 30 | 5 | int:MAPRE1 | |
| Interaction | UBE2D1 interactions | 9.02e-04 | 294 | 30 | 4 | int:UBE2D1 | |
| Interaction | R3HDM2 interactions | 9.17e-04 | 129 | 30 | 3 | int:R3HDM2 | |
| Interaction | SOCS6 interactions | 9.37e-04 | 130 | 30 | 3 | int:SOCS6 | |
| Interaction | ITGB2 interactions | 9.80e-04 | 132 | 30 | 3 | int:ITGB2 | |
| Interaction | HDAC1 interactions | 9.94e-04 | 1108 | 30 | 7 | int:HDAC1 | |
| Interaction | PSMD14 interactions | 9.95e-04 | 527 | 30 | 5 | int:PSMD14 | |
| Interaction | FLNB interactions | 1.02e-03 | 304 | 30 | 4 | int:FLNB | |
| Interaction | SERINC5 interactions | 1.03e-03 | 32 | 30 | 2 | int:SERINC5 | |
| Interaction | VIM interactions | 1.03e-03 | 804 | 30 | 6 | int:VIM | |
| Interaction | GRB2 interactions | 1.05e-03 | 806 | 30 | 6 | int:GRB2 | |
| Interaction | ANAPC5 interactions | 1.11e-03 | 138 | 30 | 3 | int:ANAPC5 | |
| Interaction | YTHDF2 interactions | 1.12e-03 | 312 | 30 | 4 | int:YTHDF2 | |
| Interaction | CNOT7 interactions | 1.16e-03 | 140 | 30 | 3 | int:CNOT7 | |
| Interaction | COL17A1 interactions | 1.17e-03 | 34 | 30 | 2 | int:COL17A1 | |
| Interaction | CNOT10 interactions | 1.19e-03 | 141 | 30 | 3 | int:CNOT10 | |
| Interaction | SMG7 interactions | 1.22e-03 | 319 | 30 | 4 | int:SMG7 | |
| Interaction | UCHL5 interactions | 1.22e-03 | 319 | 30 | 4 | int:UCHL5 | |
| Interaction | KRT26 interactions | 1.24e-03 | 35 | 30 | 2 | int:KRT26 | |
| Interaction | KRT25 interactions | 1.24e-03 | 35 | 30 | 2 | int:KRT25 | |
| Interaction | GLDC interactions | 1.25e-03 | 321 | 30 | 4 | int:GLDC | |
| Interaction | DAZL interactions | 1.28e-03 | 145 | 30 | 3 | int:DAZL | |
| Interaction | CPEB1 interactions | 1.31e-03 | 146 | 30 | 3 | int:CPEB1 | |
| Cytoband | 12q13.13 | 9.49e-04 | 67 | 31 | 2 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 3.35e-03 | 127 | 31 | 2 | chr2q24 | |
| GeneFamily | EF-hand domain containing|Plakins | 5.11e-05 | 8 | 25 | 2 | 939 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.40e-04 | 25 | 25 | 2 | 775 | |
| GeneFamily | Keratins, type II | 6.31e-04 | 27 | 25 | 2 | 609 | |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN | 2.26e-05 | 141 | 31 | 4 | M7720 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 3.44e-05 | 157 | 31 | 4 | M7733 | |
| Coexpression | GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP | 8.15e-05 | 196 | 31 | 4 | M5252 | |
| Coexpression | GSE3982_MAC_VS_BCELL_DN | 8.31e-05 | 197 | 31 | 4 | M5495 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 8.64e-05 | 199 | 31 | 4 | M9124 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_UP | 8.81e-05 | 200 | 31 | 4 | M9646 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP | 8.81e-05 | 200 | 31 | 4 | M4033 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 8.79e-06 | 806 | 29 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 1.56e-05 | 407 | 29 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-07 | 185 | 31 | 5 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | droplet-Bladder-Unstain|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 196 | 31 | 4 | f240056e63aca02f25ea29bc9d34eedcf0f1c811 | |
| ToppCell | droplet-Bladder-Unstain-18m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 196 | 31 | 4 | 0d040ae2ce8a0e1a59145a9b9eaa979239c477ff | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.02e-05 | 197 | 31 | 4 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.02e-05 | 197 | 31 | 4 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| Drug | NSC37726 | 5.03e-06 | 3 | 30 | 2 | CID000003302 | |
| Drug | U-1373 | 5.03e-06 | 3 | 30 | 2 | CID000102133 | |
| Drug | AsF5 | 2.51e-05 | 6 | 30 | 2 | CID000082223 | |
| Drug | 3-buten-1-ol | 3.51e-05 | 7 | 30 | 2 | CID000069389 | |
| Disease | cortical thickness | 1.12e-05 | 1113 | 30 | 8 | EFO_0004840 | |
| Disease | cortical surface area measurement | 4.35e-05 | 1345 | 30 | 8 | EFO_0010736 | |
| Disease | Tinnitus | 3.11e-04 | 130 | 30 | 3 | HP_0000360 | |
| Disease | body surface area | 4.39e-04 | 643 | 30 | 5 | EFO_0022196 | |
| Disease | neuroimaging measurement | 6.27e-04 | 1069 | 30 | 6 | EFO_0004346 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSSSAGGVSGSSVTG | 6 | Q96DE5 | |
| TGSESSGSVGSSTGS | 406 | Q15032 | |
| SGMGSSSGSIQTSGG | 596 | Q01546 | |
| SGSSVATSGQQSGGT | 21 | O14990 | |
| SVVSGSTSTGGISGG | 461 | P19013 | |
| VSGSTGVSAGSITAS | 1781 | Q7Z5P9 | |
| SVEATTSAGSGNTAG | 1906 | Q7Z5P9 | |
| RTGTTGQSGAESGTT | 2316 | Q7Z5P9 | |
| SGTTGTLSGGSSTTR | 2546 | Q7Z5P9 | |
| SVIGTRTTGTSSGGS | 2771 | Q7Z5P9 | |
| RTTGTSSGGSGATRS | 2776 | Q7Z5P9 | |
| TTISSVGGTGTTGQS | 3006 | Q7Z5P9 | |
| GVTGTTGSSAGVTGT | 3761 | Q7Z5P9 | |
| GVTGTTTVSAGVTGT | 3801 | Q7Z5P9 | |
| TGQSVGVTGTTRSSG | 3906 | Q7Z5P9 | |
| TGTVGSSAVVTGTTG | 4171 | Q7Z5P9 | |
| TETTGSSTGVTGATG | 4351 | Q7Z5P9 | |
| SGGVTGTSGISAEVT | 4816 | Q7Z5P9 | |
| SAGVTGTIGSSAGVT | 5236 | Q7Z5P9 | |
| SAGVTGTIGSSAGVT | 5616 | Q7Z5P9 | |
| GTTTVSAGVTGTTGL | 5711 | Q7Z5P9 | |
| GATGQSVGVTGTTRS | 5841 | Q7Z5P9 | |
| SVGVTGTTRSSGGVT | 5846 | Q7Z5P9 | |
| TKTTTSLGGSGTTGA | 7106 | Q7Z5P9 | |
| ETTTSLGGSGTTGAE | 7271 | Q7Z5P9 | |
| RGTGTTGSGMNTGTT | 7896 | Q7Z5P9 | |
| TGSKTGYTVTGSGTT | 8026 | Q7Z5P9 | |
| GTTASGTGREVTTGA | 36 | Q8IVH2 | |
| ATSGAGSTTSGVVSG | 1846 | Q7Z6Z7 | |
| STGSGKSSGTVSSVS | 156 | P28290 | |
| VSGTTSGSGESSGIT | 1816 | P16112 | |
| GVGTSSSMGSGVSDD | 2566 | P15924 | |
| SATTGGSTSDSAQGG | 456 | Q9H992 | |
| GTVNGVTLTSSGGST | 436 | Q96EY1 | |
| GGGSSSTGTSAITTS | 161 | Q9NSC2 | |
| SAGTGTTAAGTSSGA | 111 | Q8N4B5 | |
| TLGSTTVAAGGTSTG | 11 | Q9BVL2 | |
| GGTTATTTTASTGLS | 156 | Q9BVL2 | |
| GGATSGSSQTSISGD | 616 | Q13233 | |
| TGASGATVVSGSASG | 166 | Q15542 | |
| SGSQVVASSTSTGAG | 361 | P22670 | |
| DGNGTTSGVGTGSSV | 1066 | Q9NY46 | |
| ASSVGSQSSAGSVGS | 1111 | P51825 | |
| TSSSGVDISSGSGGS | 1196 | Q8IWN7 | |
| SGTASTVGGTTGSTA | 336 | Q9UMX0 | |
| TVGGTTGSTASGTSG | 341 | Q9UMX0 | |
| GGGATGATTAAVSTS | 6 | Q92545 | |
| SVSGSGSTAGSRTGS | 4616 | Q15149 | |
| HGVSSGSSSSGGTPV | 911 | Q9NPG3 | |
| ESSAGAGTGTGTSTP | 131 | Q5T0B9 | |
| GSVSSSTGAISTTTG | 2931 | Q5T4S7 | |
| TGGTVESDGSTESTG | 666 | Q8NDV7 | |
| SSSSTGSEVGGQSTG | 561 | Q9UPQ9 | |
| THGTTSICSVTSGAG | 26 | Q96CT2 |